E
Immunocore Holdings plc
IMCR
$29.72
-$0.32-1.07%
E
Sell
3/3/2025Downgrade
Immunocore Holdings plc (IMCR) was downgraded to E+ from D- on 3/3/2025 due to a significant decline in the growth index, volatility index and solvency index. Earnings per share declined from $0.17 to -$0.475, and operating cash flow declined 166.03% from $21.13M to -$13.95M.
Immunocore Holdings plc (IMCR) was downgraded to E+ from D- on 3/3/2025 due to a significant decline in the growth index, volatility index and solvency index. Earnings per share declined from $0.17 to -$0.475, and operating cash flow declined 166.03% from $21.13M to -$13.95M.
D
Sell
2/13/2025Upgraded
Immunocore Holdings plc (IMCR) was upgraded to D- from E+ on 2/13/2025 due to an increase in the total return index, volatility index and valuation index.
Immunocore Holdings plc (IMCR) was upgraded to D- from E+ on 2/13/2025 due to an increase in the total return index, volatility index and valuation index.
E
Sell
1/29/2025Downgrade
Immunocore Holdings plc (IMCR) was downgraded to E+ from D- on 1/29/2025 due to a decline in the volatility index and valuation index.
Immunocore Holdings plc (IMCR) was downgraded to E+ from D- on 1/29/2025 due to a decline in the volatility index and valuation index.
D
Sell
1/13/2025Upgraded
Immunocore Holdings plc (IMCR) was upgraded to D- from E+ on 1/13/2025 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.2323 to $0.17, EBIT increased 46.92% from -$16.02M to -$8.5M, and total revenue increased 6.43% from $75.4M to $80.25M.
Immunocore Holdings plc (IMCR) was upgraded to D- from E+ on 1/13/2025 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.2323 to $0.17, EBIT increased 46.92% from -$16.02M to -$8.5M, and total revenue increased 6.43% from $75.4M to $80.25M.
E
Sell
6/13/2024Downgrade
Immunocore Holdings plc (IMCR) was downgraded to E+ from D- on 6/13/2024 due to a large decline in the solvency index, volatility index and total return index. Debt to equity increased from 0.13 to 1.22.
Immunocore Holdings plc (IMCR) was downgraded to E+ from D- on 6/13/2024 due to a large decline in the solvency index, volatility index and total return index. Debt to equity increased from 0.13 to 1.22.
D
Sell
3/14/2023Downgrade
Immunocore Holdings Limited (IMCR) was downgraded to D- from D on 3/14/2023 due to a significant decline in the growth index and total return index. Earnings per share declined from $0.1413 to -$0.6342, EBIT declined 460.91% from $7.27M to -$26.23M, and operating cash flow declined 25.66% from $9.53M to $7.08M.
Immunocore Holdings Limited (IMCR) was downgraded to D- from D on 3/14/2023 due to a significant decline in the growth index and total return index. Earnings per share declined from $0.1413 to -$0.6342, EBIT declined 460.91% from $7.27M to -$26.23M, and operating cash flow declined 25.66% from $9.53M to $7.08M.
D
Sell
2/23/2023Upgraded
Immunocore Holdings Limited (IMCR) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
Immunocore Holdings Limited (IMCR) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
Immunocore Holdings Limited (IMCR) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
Immunocore Holdings Limited (IMCR) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
5/16/2022Upgraded
Immunocore Holdings Limited (IMCR) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and total return index.
Immunocore Holdings Limited (IMCR) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and total return index.
E
Sell
5/13/2022Downgrade
Immunocore Holdings Limited (IMCR) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
Immunocore Holdings Limited (IMCR) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
D
Sell
5/4/2022Upgraded
Immunocore Holdings Limited (IMCR) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and volatility index.
Immunocore Holdings Limited (IMCR) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and volatility index.
E
Sell
4/20/2022Downgrade
Immunocore Holdings Limited (IMCR) was downgraded to E+ from D- on 4/20/2022 due to a decline in the valuation index.
Immunocore Holdings Limited (IMCR) was downgraded to E+ from D- on 4/20/2022 due to a decline in the valuation index.
D
Sell
3/4/2022Downgrade
Immunocore Holdings Limited (IMCR) was downgraded to D- from D on 3/4/2022 due to a noticeable decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.9481 to -$1.2137, EBIT declined 20.36% from -$42.65M to -$51.33M, and the quick ratio declined from 5.1 to 4.17.
Immunocore Holdings Limited (IMCR) was downgraded to D- from D on 3/4/2022 due to a noticeable decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.9481 to -$1.2137, EBIT declined 20.36% from -$42.65M to -$51.33M, and the quick ratio declined from 5.1 to 4.17.
D
Sell
11/9/2021Upgraded
Immunocore Holdings Limited (IMCR) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
Immunocore Holdings Limited (IMCR) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
Immunocore Holdings Limited (IMCR) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
Immunocore Holdings Limited (IMCR) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
D
Sell
5/3/2021None
Immunocore Holdings plc (IMCR) was downgraded to D from U on 05/03/2021.
Immunocore Holdings plc (IMCR) was downgraded to D from U on 05/03/2021.
NASDAQ
03/18/2025 11:02AM Eastern
Quotes delayed
